Renaissance Technologies’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-569,470
Closed -$4.83M 3232
2013
Q3
$4.83M Sell
569,470
-392,601
-41% -$2.48M 0.01% 1187
2013
Q2
$3.95M Buy
+962,071
New +$5.17M 0.01% 1224

Renaissance Technologies's ASTX Position: Q4 2013 in Review

Renaissance Technologies sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 569,470 shares — an estimated $4.83M sold.

Renaissance Technologies first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $4.83M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Renaissance Technologies reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Renaissance Technologies sold 569,470 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $4.83M.
  • Renaissance Technologies first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Renaissance Technologies's ASTEX PHARMACEUTICALS, INC COM position peaked at $4.83M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.